Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MegaCarti for knee cartilage injury versus microfracture alone
KCT0008226Phase 4Completed
- Sponsor
- L&C BIO
- Start
- May 2023
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of MegaCart in Knee cartilage injury (2 arms), sponsored by L&C BIO. Primary endpoint: Pain score of KOOS. Started May 2023; status: completed.
02
Drugs
MegaCart
03
Conditions
Knee cartilage injury
Beyond the preview
Go deeper on KCT0008226.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0008226.